Pierre François Rigaux

KiOmed Pharma SA develops pharmaceutical products. It offers animal-free, ultrapure chitosan-based breakthrough biomaterials for the development of safer and highly efficient therapeutic medical devices and implants for joint health, ophthalmology, tissue engineering and biosurgery. The company was founded by Francois Blondel and Yves Henrotin in 2015 and is headquartered in Herstal, Belgium.

Myocene SA is a sports technology company based in Liege, Belgium. Myocene uses patented algorithms to deliver fast, accurate, objective, and quantifiable measurements of muscle fatigue levels. The Belgian company's technology, which has been tested on almost one thousand sportspeople, combines muscle electrostimulation and force sensors to calculate an individual's muscle fatigue index in just two minutes. Myocene's devices are aimed at the entire professional and semi-professional sports market and provide an objective assessment of muscle fatigue levels, a key parameter in improving athletic performance. The company was founded in 2020 and Pierre François Rigaux has been the CEO of the company since 2020.

CEFALY-Technology BVBA engages in the development, manufacture, and sale of migraine treating and preventing medical device. The company was founded by Pierre-Yves Muller and Pierre Fran?ois Rigaux in 2004 and is headquartered in Seraing, Belgium.